|
1
|
Wild S, Roglic G, Green A, Sicree R and
King H: Global prevalence of diabetes: estimates for the year 2000
and projections for 2030. Diabetes Care. 27:1047–1053.
2004.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Kim SM, Lee JS, Lee J, Na JK, Han JH, Yoon
DK, Baik SH, Choi DS and Choi KM: Prevalence of diabetes and
impaired fasting glucose in Korea: Korean National Health and
Nutrition Survey 2001. Diabetes Care. 29:226–231. 2006.PubMed/NCBI View Article : Google Scholar
|
|
3
|
DeFronzo RA: Pathogenesis of type 2
diabetes mellitus. Med Clin North Am. 88:787–835, ix.
2004.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Zhao BT, Le DD, Nguyen PH, Ali MY, Choi
JS, Min BS, Shin HM, Rhee HI and Woo MH: PTP1B, α-glucosidase, and
DPP-IV inhibitory effects for chromene derivatives from the leaves
of Smilax china L. Chem Biol Interact. 253:27–37. 2016.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Li ZP, Song YH, Uddin Z, Wang Y and Park
KH: Inhibition of protein tyrosine phosphatase 1B (PTP1B) and
α-glucosidase by xanthones from Cratoxylum cochinchinense, and
their kinetic characterization. Bioorg Med Chem. 26:737–746.
2018.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Yazbeck R, Howarth GS and Abbott CA:
Dipeptidyl peptidase inhibitors, an emerging drug class for
inflammatory disease? Trends Pharmacol Sci. 30:600–607.
2009.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Hopsu-Havu VK and Glenner GG: A new
dipeptide naphthylamidase hydrolyzing
glycyl-prolyl-beta-naphthylamide. Histochemie. 7:197–201.
1966.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Gorrell MD, Gysbers V and McCaughan GW:
CD26: A multifunctional integral membrane and secreted protein of
activated lymphocytes. Scand J Immunol. 54:249–264. 2001.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Morimoto C and Schlossman SF: The
structure and function of CD26 in the T-cell immune response.
Immunol Rev. 161:55–70. 1998.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Drucker DJ: Dipeptidyl peptidase-4
inhibition and the treatment of type 2 diabetes: Preclinical
biology and mechanisms of action. Diabetes Care. 30:1335–1343.
2007.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Mulvihill EE and Drucker DJ: Pharmacology,
physiology, and mechanisms of action of dipeptidyl peptidase-4
inhibitors. Endocr Rev. 35:992–1019. 2014.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Wilson PW, Pichardo FJ, Liuzzo JA,
Blackmon WJ and Reynolds BD: Amino acids in the american groundnut
(Apios americana). J Food Sci. 52:224–225. 1987.
|
|
13
|
Ichige M, Fukuda E, Miida S, Hattan J,
Misawa N, Saito S, Fujimaki T, Imoto M and Shindo K: Novel
isoflavone glucosides in groundnut (Apios americana Medik)
and their antiandrogenic activities. J Agric Food Chem.
61:2183–2187. 2013.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Kaneta H, Koda M, Saito S, Imoto M, Kawada
M, Yamazaki Y, Momose I and Shindo K: Biological activities of
unique isoflavones prepared from Apios americana Medik.
Biosci Biotechnol Biochem. 80:774–778. 2016.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Kim JH, Kim HY, Kang SY, Kim YH and Jin
CH: Soluble epoxide hydrolase inhibitory activity of components
isolated from Apios americana Medik. Molecules.
22(1432)2017.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Kim JH, Kim HY, Kang SY, Kim JB, Kim YH
and Jin CH: Chemical constituents from Apios americana and
their inhibitory activity on tyrosinase. Molecules.
23(232)2018.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Iwai K and Matsue H: Ingestion of Apios
americana Medikus tuber suppresses blood pressure and improves
plasma lipids in spontaneously hypertensive rats. Nutr Res.
27:218–224. 2007.
|
|
18
|
Gilbert ER and Liu D: Anti-diabetic
functions of soy isoflavone genistein: Mechanisms underlying its
effects on pancreatic β-cell function. Food Funct. 4:200–212.
2013.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Kim HY, Kim JH, So Y, Kang SY, Jeong HG
and Jin CH: Anti-inflammatory effect of lupinalbin A isolated from
Apios americana on lipopolysaccharide-treated RAW264.7
cells. Molecules. 23(583)2018.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Bai Y, Xu Y, Chang J, Wang X, Zhao Y and
Yu Z: Bioactives from stems and leaves of mung beans (Vigna
radiata L.). J Funct Foods. 25:314–322. 2016.
|
|
21
|
Yang D, Xie H, Jiang Y and Wei X:
Phenolics from strawberry cv. Falandi and their antioxidant and
α-glucosidase inhibitory activities. Food Chem. 194:857–863.
2016.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Kim JH, Ryu YB, Lee WS and Kim YH:
Neuraminidase inhibitory activities of quaternary isoquinoline
alkaloids from Corydalis turtschaninovii rhizome. Bioorg Med Chem.
22:6047–6052. 2014.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Meng XY, Zhang HX, Mezei M and Cui M:
Molecular docking: A powerful approach for structure-based drug
discovery. Curr Comput Aided Drug Des. 7:146–157. 2011.PubMed/NCBI View Article : Google Scholar
|
|
24
|
de Ruyck J, Brysbaert G, Blossey R and
Lensink MF: Molecular docking as a popular tool in drug design, an
in silico travel. Adv Appl Bioinform Chem. 9:1–11. 2016.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Heitz MP and Rupp JW: Determining mushroom
tyrosinase inhibition by imidazolium ionic liquids: A spectroscopic
and molecular docking study. Int J Biol Macromol. 107 (Pt
B):1971–1981. 2018.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Seong SH, Ali MY, Kim HR, Jung HA and Choi
JS: BACE1 inhibitory activity and molecular docking analysis of
meroterpenoids from Sargassum serratifolium. Bioorg Med Chem.
25:3964–3970. 2017.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Fan J, Johnson MH, Lila MA, Yousef G and
de Mejia EG: Berry and citrus phenolic compounds inhibit dipeptidyl
peptidase IV: Implications in diabetes management. Evid Based
Complement Alternat Med. 2013(479505)2013.PubMed/NCBI View Article : Google Scholar
|
